Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,248 | 391 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,238 | 61 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,088 | 58 | $0 (2024) |
| GlaxoSmithKline, LLC. | $889.21 | 71 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $565.87 | 24 | $0 (2024) |
| Philips Electronics North America Corporation | $427.99 | 27 | $0 (2023) |
| Insmed, Inc. | $256.33 | 16 | $0 (2024) |
| Mylan Specialty L.P. | $238.20 | 12 | $0 (2024) |
| GENZYME CORPORATION | $237.77 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $231.75 | 14 | $0 (2024) |
| United Therapeutics Corporation | $225.05 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,535 | 130 | AstraZeneca Pharmaceuticals LP ($550.20) |
| 2023 | $1,463 | 76 | AstraZeneca Pharmaceuticals LP ($230.71) |
| 2022 | $1,526 | 93 | GlaxoSmithKline, LLC. ($270.73) |
| 2021 | $1,723 | 92 | Boehringer Ingelheim Pharmaceuticals, Inc. ($534.60) |
All Payment Transactions
391 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $15.56 | General |
| Category: Medical Device | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $21.54 | General |
| Category: HFCWO | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.80 | General |
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $30.66 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $6.79 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/02/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: VACCINES | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $16.42 | General |
| Category: HFCWO | ||||||
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $16.82 | General |
| Category: Medical Device | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.57 | General |
| Category: HFCWO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,150 | 1,374 | $247,889 | $82,856 |
| 2022 | 12 | 1,307 | 1,724 | $310,281 | $103,123 |
| 2021 | 15 | 1,418 | 1,775 | $324,674 | $113,259 |
| 2020 | 13 | 1,214 | 1,559 | $277,190 | $86,610 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 563 | 761 | $159,810 | $57,762 | 36.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 47 | $13,395 | $5,250 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 93 | 96 | $14,400 | $5,241 | 36.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 118 | 119 | $17,850 | $4,092 | 22.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 110 | 111 | $12,765 | $3,617 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $9,920 | $3,277 | 33.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 109 | 110 | $16,170 | $2,577 | 15.9% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 29 | 36 | $1,332 | $438.48 | 32.9% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 39 | 42 | $1,722 | $424.71 | 24.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 19 | 21 | $525.00 | $176.40 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 568 | 901 | $189,210 | $68,114 | 36.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 67 | 93 | $26,505 | $10,864 | 41.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 61 | 61 | $19,520 | $5,849 | 30.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 142 | 146 | $21,900 | $5,085 | 23.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 139 | 142 | $16,330 | $4,665 | 28.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 134 | 138 | $20,286 | $3,328 | 16.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $4,745 | $1,762 | 37.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 29 | $4,350 | $1,438 | 33.1% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 47 | 77 | $2,849 | $982.89 | 34.5% |
| 94664 | Evaluation of use of breathing device | Office | 2022 | 71 | 76 | $3,116 | $808.54 | 25.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 15 | 18 | $720.00 | $137.78 | 19.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 25 | 30 | $750.00 | $88.77 | 11.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 572 | 890 | $187,010 | $70,482 | 37.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 84 | 111 | $30,510 | $12,978 | 42.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 83 | 83 | $25,080 | $8,445 | 33.7% |
About Anna Paylor
Anna Paylor is a Nurse Practitioner healthcare provider based in Wilmington, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2017. The National Provider Identifier (NPI) number assigned to this provider is 1134654056.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anna Paylor has received a total of $7,248 in payments from pharmaceutical and medical device companies, with $2,535 received in 2024. These payments were reported across 391 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($7,248).
As a Medicare-enrolled provider, Paylor has provided services to 5,089 Medicare beneficiaries, totaling 6,432 services with total Medicare billing of $385,848. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Wilmington, NC
- Active Since 04/28/2017
- Last Updated 04/28/2017
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1134654056
Products in Payments
- FASENRA (Biological) $657.29
- TRELEGY ELLIPTA (Drug) $580.31
- DUPIXENT (Biological) $491.65
- OFEV (Drug) $468.17
- GLASSIA (Biological) $468.00
- STIOLTO RESPIMAT (Drug) $421.20
- (8874) inCourage (Device) $387.68
- TEZSPIRE (Biological) $293.85
- Arikayce (Drug) $256.33
- Sunosi (Drug) $224.58
- NUCALA (Biological) $213.01
- TYVASO (Drug) $203.76
- BREZTRI (Drug) $171.78
- XYWAV (Drug) $153.37
- YUPELRI (Drug) $151.10
- Prolastin-C Liquid (Biological) $128.81
- AirDuo Digihaler (Drug) $122.61
- ACTHAR (Biological) $104.54
- ZERBAXA (Drug) $99.64
- CUVITRU (Biological) $97.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Wilmington
Bridgette Williams, Fnp, FNP
Nurse Practitioner — Payments: $32,695
Mrs. Colleen Ditro, Apn, APN
Nurse Practitioner — Payments: $16,224
Lauren Gardner, Np, NP
Nurse Practitioner — Payments: $13,768
Edith Saffo, Np, NP
Nurse Practitioner — Payments: $12,329
Rebecca Maphis
Nurse Practitioner — Payments: $12,076
Jennifer Hubbard, Aprn, APRN
Nurse Practitioner — Payments: $10,691